Beijing University of Chinese Medicine Pharmaceutical Company

Beijing University of Chinese Medicine Pharmaceutical Company is a state-owned enterprise directly affiliated with the Beijing University of Chinese Medicine. Established to bridge the gap between academic research and industrial production, the company specializes in the development, manufacturing, and commercialization of Traditional Chinese Medicine (TCM) products. Its flagship portfolio includes the widely recognized Qingkailing series, which is a staple in Chinese clinical practice for treating respiratory infections and inflammatory conditions. The company operates modern, GMP-certified facilities that focus on the scientific modernization and standardization of herbal therapies. By leveraging the research capabilities of its parent university, it remains a key player in the modernization of TCM within the Chinese healthcare system.